FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000459783> ?p ?o ?g. }

• W2000459783 endingPage "1709" @default.
• W2000459783 startingPage "1704" @default.
• W2000459783 abstract "We evaluated the feasibility and toxicity of bevacizumab in combination with sequential high-dose (HD) ifosfamide, carboplatin and etoposide refractory to standard chemotherapy in patients with sarcoma and germ cell cancer (GCC). Sixteen patients (13 sarcomas, 3 GCC) received SD-ICE followed by 4 cycles of HD-ICE, qd22 with stem cell support in combination with bevacizumab. All 16 patients were evaluable for toxicity and efficacy, and received 51 cycles (median 3.3). There was no increase in toxicity except of a relatively high incidence of ifosfamide encephalopathy in 17 cycles when compared with previous HD-ICE protocols. One almost complete response in the patient with GCC, previously progressive with three preceding protocols, was observed. Six patients had a partial response (sarcoma 4/13 patients; GCC 2/3 patients), and five patients stable disease (sarcoma 5/13 patients). The median PFS/OS for sarcoma was 5 months (confidence interval (CI): 3.1–6.9) and 13 months (CI: 3.6–24.4), respectively. To our knowledge, this is the first report of the addition of bevacizumab to HD-ICE. This combination did not show new unexpected toxicities except for a relatively high rate of ifosfamide encephalopathy. The efficacy in these heavily pretreated patients including possible reversal of chemotherapy resistance by the addition of bevacizumab indicates a possible potential of bevacizumab in this combination." @default.
• W2000459783 created "2016-06-24" @default.
• W2000459783 creator A5013984169 @default.
• W2000459783 creator A5015232096 @default.
• W2000459783 creator A5023767824 @default.
• W2000459783 creator A5033747457 @default.
• W2000459783 creator A5046914814 @default.
• W2000459783 creator A5051197527 @default.
• W2000459783 creator A5059391185 @default.
• W2000459783 creator A5088224953 @default.
• W2000459783 creator A5091058723 @default.
• W2000459783 date "2010-03-15" @default.
• W2000459783 modified "2023-10-13" @default.
• W2000459783 title "Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study" @default.
• W2000459783 cites W1536496102 @default.
• W2000459783 cites W159104142 @default.
• W2000459783 cites W1637363978 @default.
• W2000459783 cites W1867232617 @default.
• W2000459783 cites W1963813054 @default.
• W2000459783 cites W1966309113 @default.
• W2000459783 cites W1976026262 @default.
• W2000459783 cites W1998713471 @default.
• W2000459783 cites W1999305938 @default.
• W2000459783 cites W2000607921 @default.
• W2000459783 cites W2021520631 @default.
• W2000459783 cites W2057343969 @default.
• W2000459783 cites W2069119289 @default.
• W2000459783 cites W2069496194 @default.
• W2000459783 cites W2095645261 @default.
• W2000459783 cites W2096403824 @default.
• W2000459783 cites W2098114704 @default.
• W2000459783 cites W2105894548 @default.
• W2000459783 cites W2107230638 @default.
• W2000459783 cites W2127745545 @default.
• W2000459783 cites W2142564546 @default.
• W2000459783 cites W2144530818 @default.
• W2000459783 cites W2153942473 @default.
• W2000459783 cites W2154594400 @default.
• W2000459783 cites W2157769714 @default.
• W2000459783 cites W4205915684 @default.
• W2000459783 cites W4247618793 @default.
• W2000459783 cites W4250168109 @default.
• W2000459783 cites W74687677 @default.
• W2000459783 doi "https://doi.org/10.1038/bmt.2010.50" @default.
• W2000459783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20228848" @default.
• W2000459783 hasPublicationYear "2010" @default.
• W2000459783 type Work @default.
• W2000459783 sameAs 2000459783 @default.
• W2000459783 citedByCount "7" @default.
• W2000459783 countsByYear W20004597832012 @default.
• W2000459783 countsByYear W20004597832013 @default.
• W2000459783 countsByYear W20004597832016 @default.
• W2000459783 crossrefType "journal-article" @default.
• W2000459783 hasAuthorship W2000459783A5013984169 @default.
• W2000459783 hasAuthorship W2000459783A5015232096 @default.
• W2000459783 hasAuthorship W2000459783A5023767824 @default.
• W2000459783 hasAuthorship W2000459783A5033747457 @default.
• W2000459783 hasAuthorship W2000459783A5046914814 @default.
• W2000459783 hasAuthorship W2000459783A5051197527 @default.
• W2000459783 hasAuthorship W2000459783A5059391185 @default.
• W2000459783 hasAuthorship W2000459783A5088224953 @default.
• W2000459783 hasAuthorship W2000459783A5091058723 @default.
• W2000459783 hasBestOaLocation W20004597831 @default.
• W2000459783 hasConcept C126322002 @default.
• W2000459783 hasConcept C141071460 @default.
• W2000459783 hasConcept C142724271 @default.
• W2000459783 hasConcept C143998085 @default.
• W2000459783 hasConcept C2776694085 @default.
• W2000459783 hasConcept C2777506904 @default.
• W2000459783 hasConcept C2777802072 @default.
• W2000459783 hasConcept C2778119113 @default.
• W2000459783 hasConcept C2778239845 @default.
• W2000459783 hasConcept C2778256501 @default.
• W2000459783 hasConcept C2780376820 @default.
• W2000459783 hasConcept C2781451048 @default.
• W2000459783 hasConcept C71924100 @default.
• W2000459783 hasConcept C90924648 @default.
• W2000459783 hasConceptScore W2000459783C126322002 @default.
• W2000459783 hasConceptScore W2000459783C141071460 @default.
• W2000459783 hasConceptScore W2000459783C142724271 @default.
• W2000459783 hasConceptScore W2000459783C143998085 @default.
• W2000459783 hasConceptScore W2000459783C2776694085 @default.
• W2000459783 hasConceptScore W2000459783C2777506904 @default.
• W2000459783 hasConceptScore W2000459783C2777802072 @default.
• W2000459783 hasConceptScore W2000459783C2778119113 @default.
• W2000459783 hasConceptScore W2000459783C2778239845 @default.
• W2000459783 hasConceptScore W2000459783C2778256501 @default.
• W2000459783 hasConceptScore W2000459783C2780376820 @default.
• W2000459783 hasConceptScore W2000459783C2781451048 @default.
• W2000459783 hasConceptScore W2000459783C71924100 @default.
• W2000459783 hasConceptScore W2000459783C90924648 @default.
• W2000459783 hasIssue "12" @default.
• W2000459783 hasLocation W20004597831 @default.
• W2000459783 hasLocation W20004597832 @default.
• W2000459783 hasOpenAccess W2000459783 @default.
• W2000459783 hasPrimaryLocation W20004597831 @default.
• W2000459783 hasRelatedWork W1975212853 @default.
• W2000459783 hasRelatedWork W1998553286 @default.

• next